Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

Pan-Montojo, Francisco, Schwarz, Mathias, Winkler, Clemens, Arnhold, Mike, O'Sullivan, Gregory A., Pal, Arun, Said, Jonas, Marsico, Giovanni +5 more·2012·Scientific Reports
DOI 10.1038/srep00898

Cited by (403)

Items 301–400 of 403

  1. Recent perspectives in neurology
    Tjalf Ziemssen, Alexander Storch · 2013 · Journal of Neural Transmission
  2. Sex Specific Effects of Environmental Toxin‐Derived Alpha Synuclein on Enteric Neuronal‐Epithelial Interactions
    Hayley Templeton, Alexis Ehrlich, Luke Schwerdtfeger, Julietta A. Sheng, Ronald B. Tjalkens, Stuart A. Tobet · 2025 · Neurogastroenterology & Motility
  3. Alpha Pinene Affects Intestinal Permeability and Protects the Gastrointestinal System Against Rotenone Toxicity via the Keap1/Nrf2 Pathway in Rats
    Berna Tezcan Yavuz, Emel Kabartan, Cansın Şirin, Gülay Hacıoğlu, Selma Cırrık, Canberk Tomruk · 2025 · Neurotoxicity Research
  4. Approaches to the Early Diagnosis of Parkinson’s Disease
    Е А Катунина, E. P. Ilina, G. I. Sadekhova, E. I. Gaisenuk · 2020 · Neuroscience and Behavioral Physiology
  5. Pesticide Exposure as a Risk Factor for Parkinson's Disease
    Fatima Ez-Zahraa Saad, Aaron Pambu Lelo, Kamal Smimih, Bilal El‐Mansoury, Manal lkhanouchi, Souad El Amine, Abdelali Bitar · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  6. Gastroparesia y otros síntomas gastrointestinales en la enfermedad de Parkinson
    Diego Santos‐García, Teresa de Deus Fonticoba, Cristina Tejera Pérez, Irene Expósito Ruiz, Ester Suárez Castro, Pedro Carpintero Briones, Mercedes Macías Arribi · 2015 · Revista de Neurología
  7. Prospective cohort study of patients with early gastric cancer to detect prodromal Parkinson disease (EGC-PPD): A study protocol and baseline characteristics
    Chaewon Shin, Han‐Kwang Yang, Sung‐Hye Park, Hyukjoon Lee, Seong‐Ho Kong, Yun‐Suhk Suh, Yeon‐Ju Huh, Yun Jeong Kim, So-Yong Park, Tae‐Beom Ahn et al. · 2019 · Journal of Clinical Neuroscience
  8. The role of infectious agents in the development of neurodegenerative diseases
    Igor Litvinenko, Vladimir Yu. Lobzin, Vladimir A. Pushkarev · 2021 · Russian Military Medical Academy Reports
  9. The development and emerging trends in Parkinson’s disease from the perspective of mitochondrial dysfunction: a bibliometric analysis using CiteSpace
    Yanzhi Lu, Xuannan Chen, Yu Lai · 2025 · Journal of Neurology
  10. Early alpha-synuclein accumulation, oxidative stress and inflammation in the proximal colon of c-rel-/- mouse model of Parkinson's disease
    Edoardo Parrella, Michele Mario Gennari, Giulia Abate, Mariachiara Pucci, Tiziana Schioppa, Daniela Bosisio, Emanuela Tirelli, Marina Benarese, Gaia Vegezzi, Maria Silletti et al. · 2025 · Neurobiology of Disease
  11. Brain-first and body-first subtypes of Lewy body disease
    Per Borghammer, Nathalie Van Den Berge, Daniela Berg, Ryōsuke Takahashi, Ronald B. Postuma, Jacob Horsager · 2026 · Nature Reviews Neurology
  12. MODELING OF PARKINSON’S DISEASE USING ENVIRONMENTAL NEUROTOXINS (REVIEW)
    Куликова Ольга Игоревна, Т. Н. Федорова, Valentina S. Orlova · 2019 · Toxicological Review
  13. The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies
    Vanessa Raeder, Lucia Batzu, Robert Untucht, Annekathrin Fehre, Alexandra Rizos, Valentina Leta, Renate Schmelz, Jochen Hampe, Sevasti Bostantjopoulou, Zoe Katsarou et al. · 2023 · Frontiers in Neurology
  14. Comprehensive review of in vitro gut-brain axis models in Parkinson’s disease research
    John Nicholas Cauba, Jihoo Woo, Russell W. Wiggins, Shizue Mito · 2025 · Brain Organoid and Systems Neuroscience Journal
  15. Ultrasonography of the vagus nerve in Parkinson’s disease: a systematic review and meta-analysis
    Yating Cui, Rui Yan, Yan Qu, Shuting Liu, X C Li · 2025 · Neurological Sciences
  16. TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation
    Bruno Ghirotto, Luís Eduardo Gonçalves, Vivien Ruder, Christina James, Elizaveta M. Gerasimova, Tania Rizo, Holger Wend, Michaela Farrell, Juan Gerez, Natalia Cecilia Prymaczok et al. · 2026 · Nature Communications
  17. Posible contribución del paraquat al desarrollo de la enfermedad de Parkinson
    Carlos A. Elena‐Real, R. Pasión-Galván, M.R. Pérez-Artés, María Puerto Rodríguez, Isabel Navarro · 2012 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  18. "Use of Anti-Inflammatory Drugs in the Treatment of Parkinson’s Disease: A Systematic Review of Perimental Studies"
    Roberto de Barros Silva · 2021 · Biomedical Journal of Scientific & Technical Research
  19. Gut-brain axis: Review on the association between Parkinson’s disease and plant lectins
    Kayvon Moin, Carly M Funk, Meagan Josephs · 2022 · Archive of Clinical Cases
  20. Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease
    Seok Jong Chung, Seun Jeon, Han Soo Yoo, Jung Han Yoon, Jee Eun Lee, Joong‐Seok Kim, Soo‐Jong Kim, Jungsu S. Oh, Jae Seung Kim, Byoung Seok Ye et al. · 2018 · Movement Disorders
  21. Hypothesis of Ascension in Idiopathic Parkinson’s Disease
    Lisa Klingelhoefer, Heinz Reichmann · 2017 · Neurology International Open
  22. The effect of opioid abuse on HIV infected nervous system
    Tong Lu, Kunhua Wang · 2020 · Ibrain
  23. Gastrointestinal Disturbances in Parkinson’s Disease Including the Management of Sialorrhea
    Wolfgang H. Jost, Lisa Klingelhoefer · 2022 · Cambridge University Press eBooks
  24. Enteric Nervous System Damage by Food Contaminants: A Pathway to Neurodegeneration?
    Helena Ramos, Ana Margarida Araújo, Isabel M.P.L.V.O. Ferreira, Miguel Ângelo Faria · 2026 · Comprehensive Reviews in Food Science and Food Safety
  25. The emerging roles of gut microbiome on neurotoxic outcomes: Implications for neurological disorders
    Gokul Krishna, Meghashri Sridhar, Murali Muralidhara · 2021 · Elsevier eBooks
  26. The role of the gut microbiota in Parkinson’s disease
    N I Verugina, Oleg Semenovich Levin, Elena A. Lyashenko · 2021 · S S Korsakov Journal of Neurology and Psychiatry
  27. Toxicity Studies of Exosomes and Potential Overcome Approaches
    Phool Chandra, Zeeshan Ali, Nishat Fatma, Neetu Sachan · 2024 · Springer eBooks
  28. New insights in non-motor symptoms in Parkinson’s disease
    Cristian Falup‐Pecurariu, Alessandra Fanciulli, Rupam Borgohain, К. Ray Chaudhuri, Vinod Metta · 2024 · Frontiers research topics
  29. Gut and Parkinson’s disease
    Sujith Ovallath, Bahiya Sulthana · 2018 · Annals of Movement Disorders
  30. The role of environmental toxins and inflammation in Parkinson's disease pathophysiology: a historical perspective and research-based evidence
    Francisco J. Pan-Montojo, Kai F. Loewenbrück, Heinz Reichmann · 2020 · Elsevier eBooks
  31. Vagal motoneurons in Parkinson's disease
    Ruth E. Musgrove, Wei‐Hua Chiu, Joshua A. Goldberg · 2020 · Elsevier eBooks
  32. Relação entre a exposição ao pesticida Rotenona e o desenvolvimento de sintomas motores e não-motores da doença de Parkinson
    Jennifer Kelly Silva de Oliveira, Jociele Moreira de Carvalho, Camila Alexandre Silva, Mateus Barbosa de Lima, Paulo Matheus Freitas Cavalcante, Daniel Felipe Fernandes Paiva · 2020 · Research Society and Development
  33. Micronutrients and Parkinson’s Disease
    Shahrul Azmin, Rufaidah Md. Rani, Norlinah Mohamed Ibrahim · 2022 · Nutritional neurosciences
  34. Pathology of the enteric nervous system in Parkinson’s disease
    E.S. Pimenova, Marianna Igorevna Ruskina, Sergey Sergeevich Petrikov, Ganipa Ramazanovich Ramazanov, Olesya Bogdanovna Zavaliy · 2022 · Medical news of the North Caucasus
  35. The cytoskeletal linker protein, Ezrin, inhibits α-synuclein fibrillization and toxicity by a novel mechanism
    Maliha Shah · 2014 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
  36. Let’s not forget about the vagus and other updates on recent autonomic research
    Srikanth Muppidi, Mitchell G. Miglis · 2017 · Clinical Autonomic Research
  37. Influence of Diphenyl Diselenide on Thiol Redox Homeostasis and Electrogenic Membrane Transport in Rotenone-Induced Parkinson’s Disease
    Titilayo Ibironke Ologunagba, Bunmi Olaoluwa Olorundare, Titilope Ayoola Iyanda, Mulikat Adenike Adewole, Ige Joseph Kade · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease
    Lina A. Matschke, Marlene A. Komadowski, Annette Stöhr, Bolam Lee, Martin T. Henrich, Markus Griesbach, Susanne Rinné, Fanni F. Geibl, Wei‐Hua Chiu, James B. Koprich et al. · 2024
  39. Gut-Brain Axis in Parkinson’s Disease
    Elynn Zhou, Ulf Dettmer · 2026 · Preprints.org
  40. Role of Trichloroethylene in Parkinson’s Disease
    Samuel M. Goldman, Stephanie Whisnant Cash · 2014 · Molecular and integrative toxicology
  41. Is α-synuclein rising to the surface as a diagnostic biomarker for Parkinson disease?
    William P. Cheshire, Ronald F. Pfeiffer · 2013 · Neurology
  42. La enfermedad invisible
    Jesús Alberto Sabando Carranza, Diana Calvo Carrasco · 2013 · FMC - Formación Médica Continuada en Atención Primaria
  43. ELECTRONIC ANALOGY TO SIMULATE AND PREDICT THE DYNAMICS OF CELLULAR MECHANISM OF PARKINSON’S DISEASE STIMULATED BY ENVIRONMENTAL FACTORS
    Nivedita Chaudhary, Yogender Aggarwal, Nishant Singh, Rakesh Kumar Sinha · 2015 · Biomedical Engineering Applications Basis and Communications
  44. Protein Folding Diseases
    Engelbert Buxbaum · 2015 · Springer eBooks
  45. Parkinson durch Pestizide — BfR muss Urteil revidieren
    Friederike Klein · 2015 · DNP - Der Neurologe und Psychiater
  46. Neue Medikamente zur Behandlung des idiopathischen Parkinson-Syndroms
    Heinz Reichmann · 2016 · InFo Neurologie + Psychiatrie
  47. Muss die bisherige BfR-Stellungnahme zur Risikobewertung revidiert werden?
    Wilfried Kuhn, Manfred Gerlach, Thomas H. Müller · 2016 · NeuroTransmitter
  48. Gene-Environment Interactions Between Manganese Toxicity and Early-Onset Parkinson's Disease Genes
    Sudipta Chakraborty · 2015
  49. Überblick über den aktuellen Stand einer möglichen Assoziation zwischen Rotenon-Exposition und einer parkinsonoiden Erkrankung
    M. Bundschuh, Doris Klingelhöfer · 2013 · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie
  50. Aszensionshypothese beim idiopathischen Parkinson-Syndrom
    Lisa Klingelhoefer, Heinz Reichmann · 2017 · Aktuelle Neurologie
  51. Der Gastrointestinaltrakt rückt ins Zentrum
    Susanne A. Schneider, Günther Deuschl · 2015 · NeuroTransmitter
  52. Need for more holistic therapeutic and management strategies to understand the causal or correlative link of the Aβ amyloid pathway with Alzheimer’s disease for a more efficiënt treatment
    Jean‐Pierre Timmermans · 2018 · Peptides
  53. Investigating early functional alteration in a human iPSC-based model of Parkinson’s Disease
    Giulia Carola · 2019 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  54. Parkinsonian Toxins: From MPTP to Endogenous Neurotoxins
    Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai · 2020 · Springer eBooks
  55. Live-Imaging von Kalzium-induzierter axonaler Degeneration in transgenen Mausmodellen des Morbus Parkinson
    Julius Christian Steenken · 2020
  56. Cellular pathophysiology and basal ganglia dysfunction in Parkinson's disease: an overview
    Kai F. Loewenbrück, Francisco J. Pan-Montojo, Heinz Reichmann · 2020 · Elsevier eBooks
  57. Вплив Капікору на зміни білкових маркерів розвитку окисного стресу в мітохондріях мозку щурів за умов моделювання хвороби Паркінсона
    Olga O. Gonchar, LV Bratus', Karaban' In, Man'kovs'ka Im · 2020 · Pharmacology and Drug Toxicology
  58. Effects of HIV-1 Tat on the enteric nervous
    Joy Ngwainmbi · 2015 · VCU Scholars Compass (Virginia Commonwealth University)
  59. Immunomorphological Changes in Neuronal and Non-Neuronal Structures in the Rat Intestine in a Toxin-Induced Model of Parkinsonism
    Mikhail V. Ivanov, Kristina A. Kutukova, Р. М. Худоерков, Alla V. Stavrovskaya · 2021 · Bulletin of Experimental Biology and Medicine
  60. Automatic psychomotor function quantification in Parkinson’s disease via natural interaction with digital devices
    Teresa Arroyo‐Gallego · 2020
  61. Der Einfluss von humanem Wildtyp-Alpha-Synuclein und seinen Mutationen A30P und A53T auf das Neuritenwachstum primärer dopaminerger Mittelhirnneurone der Ratte
    Jessica Franziska Haack · 2021
  62. Faculty Opinions recommendation of Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.
    Dongsheng Cai · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  63. Faculty Opinions recommendation of Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
    Wolfgang Jahnke · 2013 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  64. Insights into correlation between intestinal flora-gut-brain axis and blood-brain barrier permeability
    Rongxuan Hua, Han Gao, Boya Wang, Yuexin Guo, Chen Liang, Lei Gao, Hong-Wei Shang, Jingdong Xu · 2022 · World Chinese Journal of Digestology
  65. Nanobody-basierter Sensor für die Zell-zu-Zell-Übertragung von α-Synuclein bei Morbus Parkinson
    Christoph Gerdes · 2021
  66. Faculty Opinions recommendation of Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.
    Roger Lemon · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  67. Faculty Opinions recommendation of The vermiform appendix impacts the risk of developing Parkinson's disease.
    JUN C. TAKAHASHI, Asuka Morizane · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  68. Faculty Opinions recommendation of Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.
    Richard J Naftalin · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  69. The role of RNA in synapse physiology and neurodegeneration in models of Parkinson´s disease
    Maria Xylaki · 2021
  70. Modelling motor and non-motor signs of early-stage Parkinson's disease
    Mikhail V. Ivanov, Kristina A. Kutukova · 2022 · Annals of Clinical and Experimental Neurology
  71. Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches
    Е А Катунина, N N Shipilova, D.A. Katunin · 2022 · S S Korsakov Journal of Neurology and Psychiatry
  72. Parkinsonian Toxins: From MPTP to Endogenous Neurotoxins
    Makoto Naoi, Wakako Maruyama, Masayo Shamoto Nagai · 2022 · Springer eBooks
  73. Microbiota: ¿Sabemos de qué estamos hablando?
    Natalia Apentchenko Eriutina · 2021 · Archivos de coloproctología
  74. Exosomes as mediators of chemical-induced toxicity
    Suryanarayana Polaka, Muktika Tekade, Nupur Vasdev, Tanisha Gupta, Bhakti Pawar, Maliheh Safavi, Rakesh Kumar Tekade · 2023 · Elsevier eBooks
  75. Fields and Exposure Periods
    Masami Ishido · 2023 · Springer eBooks
  76. PERMEABILITY OF THE BLOOD-BRAIN BARRIER IN TOXIC PARKINSONISM
    M.M. Gradinar, Ivan Vladimirovich Chernykh, Yu. V. Abalenikhina, A. V. Shchulkin, Elena Nikolaevna Yakusheva · 2024 · Problems of Biological Medical and Pharmaceutical Chemistry
  77. Facets of movement disorders– a tribute to Heinz Reichmann
    Peter Franz Riederer, Étienne C. Hirsch · 2024 · Journal of Neural Transmission
  78. Characterizing the roles of distinct ventral midbrain progenitor cell types in dopaminergic neuron development
    Emilía Sif Ásgrímsdóttir · 2024
  79. Fluid and Imaging Markers of Synuclein Pathology
    Federico Paolini Paoletti, Lorenzo Gaetani, Giovanni Bellomo, Lucilla Parnetti · 2025 · Springer eBooks
  80. The Effects of Vortioxetine on Rotenone-Induced Inflammatory Changes in Rat-Derived Enteroglial Cells: The Role of the TLR4/NFκB Signaling Pathway
    Dilara Nemutlu Samur, Erkan Maytalman, Öykü Zorlu · 2025 · OSMANGAZİ JOURNAL OF MEDICINE
  81. Additional file 1 of Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
    Lifu Sheng, Stewart, Tessandra, Dishun Yang, Eric Thorland, David Soltys, Patrick Aro, Tarek Khrisat, Xie, Zhiying, Li, Na, Liu, Zongran et al. · 2020 · Figshare
  82. Additional file 1 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  83. Additional file 10 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  84. Additional file 2 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  85. Additional file 6 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  86. Additional file 7 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  87. Additional file 5 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  88. Additional file 11 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  89. Additional file 3 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  90. Additional file 4 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  91. Additional file 12 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  92. Additional file 9 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
  93. Impact moléculaire de l’exposition subchronique par voie orale à un pesticide, le paraquat, dans un modèle murin transgénique de synucléinopathie humaine : implication du système nerveux entérique
    Nicolas Naudet · 2017 · theses.fr (ABES)
  94. Typage moléculaire des maladies neurodégénératives dues à l’agrégation de la protéine alpha synucléine
    Alexis Fenyi · 2019 · theses.fr (ABES)
  95. Contrôle de la mitophagie dans la maladie de Parkinson : Dialogue fonctionnel entre XBP1 et PINK1
    Wejdane El Manaa · 2019 · theses.fr (ABES)
  96. Les vésicules extracellulaires dans l'hépatotoxicité des hydrocarbures aromatiques polycycliques : biomarqueurs et/ou vecteurs ?
    Nettie van Meteren · 2020 · theses.fr (ABES)
  97. Molecular programming for the ultra-sensitive detection of biomarkers involved in neurodegenerative diseases
    Antoine Masurier · 2021
  98. Étude de la propagation de l'alpha-synucléine de l'hôte vers le greffon dans la maladie de Parkinson
    Maëlig Patrigeon · 2022 · theses.fr (ABES)
  99. Duodenal α-Synuclein PFF Injection Induces Vagus-Related Gut-to-Brain Pathology in C57BL/6J and A53T Transgenic Mice
    Mengfei Wang, Guangqiang Sun, Peifeng Wan, Zitong Wang, Yali Nie, Hong‐Chun Liu, Meiyu Geng, Ming Liu, Yu Zhang · 2026 · Brain Sciences
  100. Pesticide exposure and multidomain symptom burden in Parkinson’s disease: a longitudinal triangulation study
    Zhengjie Yang, Shijv Shen, Saskia Preißner, Robert Preißner · 2026 · npj Parkinson s Disease